The Three-Dimensional Structure of the Cystic Fibrosis Locus: A Dissertation
Authors
Smith, Emily M.Faculty Advisor
Job Dekker, PhDAcademic Program
Interdisciplinary Graduate ProgramUMass Chan Affiliations
Biochemistry and Molecular PharmacologyDocument Type
Doctoral DissertationPublication Date
2014-11-18Keywords
Dissertations, UMMSProtein Conformation
Cystic Fibrosis
Cystic Fibrosis Transmembrane Conductance Regulator
Gene Expression
Gene Library
Genome, Human
Luciferases
Transcription Factors
Protein Conformation
Cystic Fibrosis
Cystic Fibrosis Transmembrane Conductance Regulator
Gene Expression
Gene Library
Human Genome
Luciferases
Transcription Factors
Genetic Processes
Genetics and Genomics
Genomics
Structural Biology
Metadata
Show full item recordAbstract
The three dimensional structure of the human genome is known to play a critical role in gene function and expression. I used chromosome conformation capture (3C) and 3C-carbon copy (5C) techniques to investigate the three-dimensional structure of the cystic fibrosis transmembrane conductance regulator (CFTR) locus. This is an important disease gene that, when mutated, causes cystic fibrosis. 3C experiments identified four distinct looping elements that contact the CFTR gene promoter only in CFTR-expressing cells. Using 5C, I expanded the region of study to a 2.8 Mb region surrounding the CFTR gene. The 5C study shows 7 clear topologically associating domains (TADs) present at the locus, identical in all five cell lines tested, regardless of gene expression status. CFTR and all its known regulatory elements are contained within one TAD, suggesting TADs play a role in constraining promoters to a local search space. The four looping elements identified in the 3C experiment and confirmed in the 5C experiment were then tested for enhancer activity using a luciferase assay, which showed that elements III and IV could act as enhancers. These elements were tested against a library of human transcription factors in a yeast one-hybrid assay to identify potential binding proteins. Element III gave two strong candidates, TCF4 and LEF1. A literature search supported these transcription factors as playing a role in CFTR gene expression. Overall, this work represents a model locus that can be used to test important questions regarding the role of three dimensional looping on gene expression.DOI
10.13028/M2SK51Permanent Link to this Item
http://hdl.handle.net/20.500.14038/32106Rights
Copyright is held by the author, with all rights reserved.ae974a485f413a2113503eed53cd6c53
10.13028/M2SK51
Scopus Count
Related items
Showing items related by title, author, creator and subject.
-
Cystic fibrosis heterozygotes do not have increased platelet activationTarnow, Inge; Michelson, Alan D.; Frelinger, Andrew L. III; Linden, Matthew Dean; Li, YouFu; Fox, Marsha L.; Barnard, Marc R.; O'Sullivan, Brian P. (2007-05-29)INTRODUCTION: We have previously demonstrated platelet hyperreactivity in cystic fibrosis (CF) patients. Carriers of one CF mutation (heterozygotes) have been shown to have abnormalities related to the presence of only one-half the normal amount of CF transmembrane conductance regulator protein. Platelet hyperreactivity in CF heterozygotes would be an important cardiovascular risk factor, since approximately 1 in 25 Caucasians is a CF carrier. MATERIALS AND METHODS: We used highly sensitive assays of platelet activation to assess the difference between 16 CF heterozygotes and 16 age- and sex-matched healthy controls without CF mutations. RESULTS: We found no difference in platelet activation between CF heterozygotes and controls. CONCLUSIONS: The 50% reduction in the CF transmembrane conductance regulator protein in heterozygotes is insufficient to cause platelet activation.
-
What can we learn about fertilization from cystic fibrosisFlorman, Harvey M.; Jungnickel, Melissa K.; Sutton, Keith A. (2007-06-28)
-
In utero efficacy of cystic fibrosis gene therapy: difficult studies, positive or negativeFlotte, Terence R. (2008-05-25)
